Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-08-09

Clinical Trial Update: The Recurrence Study [NA]

View source ↗

Summary

Clinical trial update for the Recurrence Study (NCT03244215) sponsored by Hamad Medical Corporation, investigating acute ischemic stroke and transient ischemic …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Hamad Medical Corporation | Conditions: Acute Stroke, Transient Ischemic Attack | NA | Status: UNKNOWN